Genetic Characterization of the Drosophila Birt-Hogg-Dubé Syndrome Gene

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Liu, Wei ^a,b   Chen, Zhi ^a   Ma, Yansen ^a   Wu, Xiaochun ^a   Jin, Yaping ^a   Hou, Steven ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE;

ARTICLE; CONTROLLED STUDY; DBHD GENE; DROSOPHILA; FLCN GENE; GENE; GENE DELETION; GENETIC ANALYSIS; GROWTH RETARDATION; MALNUTRITION; MOLECULAR DYNAMICS; NONHUMAN; NUTRIENT SUPPLY; PHENOTYPE; YEAST;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BASE SEQUENCE; BIRT-HOGG-DUBE SYNDROME; CULTURE MEDIA; DNA PRIMERS; DROSOPHILA; ENDOREDUPLICATION; GENE TARGETING; HUMANS; LARVA; MITOSIS; POLYMERASE CHAIN REACTION; YEASTS;

ANIMALIA;

EID: 84879171618     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065869     Document Type: Article

References (27)

1. Zbar B, Alvord WG, Glenn G, Turner M, Pavlovich CP, et al. (2002) Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev 11: 393-400.
2. Menko FH, van Steensel MA, Giraud S, Friis-Hansen L, Richard S, et al. (2009) Birt-Hogg-Dubé syndrome: diagnosis and management. Lancet Oncol 10: 1199-1206.
3. Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, et al. (2008) BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet 45: 321-331.
4. Laplante M, Sabatini DM, (2012) mTOR Signaling in Growth Control and Disease. Cell 149: 274-293.
5. Baba M, Hong SB, Sharma N, Warren MB, Nickerson ML, et al. (2006) Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling. Proc Natl Acad Sci USA 103: 15552-15557.
6. Baba M, Furihata M, Hong SB, Tessarollo L, Haines DC, et al. (2008) Kidney-targeted Birt-Hogg-Dubé gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. J Natl Cancer Inst 100: 140-154.
7. Hasumi Y, Baba M, Ajima R, Hasumi H, Valera VA, et al. (2009) Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2. Proc Natl Acad Sci USA 106: 18722-18727.
8. Hartman TR, Nicolas E, Klein-Szanto A, Al-Saleem T, Cash TP, et al. (2009) The role of the Birt-Hogg-Dubé protein in mTOR activation and renal tumorigenesis. Oncogene 28: 1594-1604.
9. Hudon V, Sabourin S, Dydensborg AB, Kottis V, Ghazi A, et al. (2010) Renal tumor suppressor function of the Birt-Hogg-Dubé syndrome gene product folliculin. J Med Genet 47: 182-189.
10. Hong SB, Oh H, Valera VA, Stull J, Ngo DT, et al. (2010) Tummor suppressor FLCN inhibits tumorigenesis of a FLCN-null renal cancer cell line and regulates expression of key molecules in TGF-β signaling. Molecular Cancer 9: 160.
11. Cash TP, Gruber JJ, Hartman TR, Henske EP, Simon MC, (2011) Loss of the Birt-Hogg-Dubé tumor suppressor results in apoptotic resistance due to aberrant TGFb-mediated transcription. Oncogene 30: 2534-2546.
12. Singh SR, Zhen W, Zheng Z, Wang H, Oh SW, et al. (2006) The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance. Oncogene 25: 5933-5941.
13. Gong WJ, Golic KG, (2004) Ends-out, or replacement, gene targeting in Drosophila. Proc Natl Acad Sci USA 100: 2567-2561.
14. Perrimon N, (1998) Creating mosaics in Drosophila. Int. J. Dev. Biol. 42: 243-247.
15. Britton JS, Edgar BA, (1998) Environmental control of the cell cycle in Drosophila: nutrition activates mitotic and endoreplicative cells by distinct mechanisms. Development 125: 2149-2158.
16. Wu YT, Tan HL, Shui G, Bauvy C, Huang Q, et al. (2010) Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase. J Biol Chem. 285(14): 10850-10861.
17. Burnet B, Sang JH, (1968) Physiological genetics of melanotic tumors in Drosophila melanogaster. V. Amino acid metabolism and tumor formation in the tu bw; st su-tu strain. Genetics. 59: 211-235.
18. Sang JH, King RC, (1961) Nutritional requirements of axenically cultured Drosophila melanogaster adults. J Exp Biol. 38: 793-809.
19. Tatum EL, (1941) Vitamin B Requirements of Drosophila melanogaster. Proc Natl Acad Sci USA. 27(4): 193-197.
20. Le Rohellec M, Le Bourg E, (2009) Contrasted effects of suppressing live yeast from food on longevity, aging and resistance to several stresses in Drosophila melanogaster. Experimental Gerontology 44: 695-707.
21. Zinke I, Kirchner C, Chao LC, Tetzlaff MT, Pankratz MJ, (1999) Suppression of food intake and growth by amino acids in Drosophila: the role of pumpless, a fat body expressed gene with homology to vertebrate glycine cleavage system. Development 126: 5275-5284.
22. Layman DK, Walker DA, (2006) Potential importance of leucine in treatment of obesity and the metabolic syndrome. J. Nutr. 136: 319s-323s.
23. Li F, Yin Y, Tan B, Kong X, Wu G, (2011) Leucine nutrition in animals and humans: mTOR signaling and beyond. Amino Acids 41: 1185-1193.
24. Zhang H, Stallock JP, Ng JC, Reinhard C, Neufeld TP, (2000) Regulation of cellular growth by the Drosophila target of rapamycin dTOR. Genes Dev. 14: 2712-2724.
25. Oldham S, Montagne J, Radimerski T, Thomas G, Hafen E, (2000) Genetic and biochemical characterization of dTOR, the Drosophila homolog of the target of rapamycin. Genes Dev. 14: 2689-2694.
26. Knoblich JA, (1997) Mechanisms of asymmetric cell division during animal development. Curr. Opin. Cell Biol. 9(6): 833-841.
27. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, et al. (2010) Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141: 290-303.